AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
171.61
-6.88 (-3.85%)
At close: Jul 10, 2026, 4:00 PM EDT
170.74
-0.87 (-0.51%)
Pre-market: Jul 13, 2026, 5:40 AM EDT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of $267.14 billion as of July 13, 2026. Its market cap has increased by 23.67% in one year.
Market Cap
267.14B
Enterprise Value
293.97B
1-Year Change
23.67%
Ranking
Category
Stock Price
$171.61
Market Cap Chart
Since November 21, 2000, AstraZeneca's market cap has increased from $126.35B to $267.14B, an increase of 111.42%. That is a compound annual growth rate of 2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 265.82B | -6.72% |
| Dec 31, 2025 | 284.98B | 40.31% |
| Dec 31, 2024 | 203.11B | -2.65% |
| Dec 29, 2023 | 208.65B | -0.60% |
| Dec 30, 2022 | 209.91B | 20.44% |
| Dec 31, 2021 | 174.28B | 32.86% |
| Dec 31, 2020 | 131.17B | 1.42% |
| Dec 31, 2019 | 129.34B | 34.47% |
| Dec 31, 2018 | 96.18B | 9.54% |
| Dec 29, 2017 | 87.81B | 27.12% |
| Dec 30, 2016 | 69.07B | -19.47% |
| Dec 31, 2015 | 85.77B | -3.07% |
| Dec 31, 2014 | 88.48B | 19.53% |
| Dec 31, 2013 | 74.02B | 21.17% |
| Dec 31, 2012 | 61.09B | -6.34% |
| Dec 30, 2011 | 65.22B | -2.68% |
| Dec 31, 2010 | 67.02B | -1.37% |
| Dec 31, 2009 | 67.95B | 13.67% |
| Dec 31, 2008 | 59.78B | -7.97% |
| Dec 31, 2007 | 64.96B | -23.07% |
| Dec 29, 2006 | 84.44B | 6.23% |
| Dec 30, 2005 | 79.49B | 29.74% |
| Dec 31, 2004 | 61.26B | -26.15% |
| Dec 31, 2003 | 82.95B | 37.87% |
| Dec 31, 2002 | 60.17B | -55.10% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson & Johnson | 618.61B |
| AbbVie | 438.31B |
| Merck & Co. | 305.12B |
| Novartis AG | 281.98B |
| Novo Nordisk | 218.14B |
| Amgen | 196.12B |
| Gilead Sciences | 161.19B |
| Pfizer | 137.76B |